BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8006581)

  • 1. Human major histocompatibility complex class II-restricted T cell responses in transgenic mice.
    Woods A; Chen HY; Trumbauer ME; Sirotina A; Cummings R; Zaller DM
    J Exp Med; 1994 Jul; 180(1):173-81. PubMed ID: 8006581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
    Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
    J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells.
    Sant AJ
    J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice.
    Yamamoto K; Fukui Y; Esaki Y; Inamitsu T; Sudo T; Yamane K; Kamikawaji N; Kimura A; Sasazuki T
    J Exp Med; 1994 Jul; 180(1):165-71. PubMed ID: 8006580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mice expressing MHC class II molecules with truncated A beta cytoplasmic domains reveal signaling-independent defects in antigen presentation.
    Smiley ST; Laufer TM; Lo D; Glimcher LH; Grusby MJ
    Int Immunol; 1995 Apr; 7(4):665-77. PubMed ID: 7547694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactive trinitrophenylated peptides as antigens for class II major histocompatibility complex-restricted T cells and inducers of contact sensitivity in mice. Limited T cell receptor repertoire.
    Kohler J; Martin S; Pflugfelder U; Ruh H; Vollmer J; Weltzien HU
    Eur J Immunol; 1995 Jan; 25(1):92-101. PubMed ID: 7843258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma.
    Frandji P; Oskéritzian C; Cacaraci F; Lapeyre J; Peronet R; David B; Guillet JG; Mécheri S
    J Immunol; 1993 Dec; 151(11):6318-28. PubMed ID: 8245470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules.
    Vignali DA; Moreno J; Schiller D; Hämmerling GJ
    J Exp Med; 1992 Apr; 175(4):925-32. PubMed ID: 1552288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DR alpha: E beta heterodimers in DRA transgenic mice hinder expression of E alpha: E beta molecules and are more efficient in antigen presentation.
    Trembleau S; Giacomini P; Guéry JC; Setini A; Hammer J; Sette A; Appella E; Adorini L
    Int Immunol; 1995 Dec; 7(12):1927-38. PubMed ID: 8746562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR4 (DRB1*0401) transgenic mice expressing an altered CD4-binding site: specificity and magnitude of DR4-restricted T cell response.
    Pan S; Trejo T; Hansen J; Smart M; David CS
    J Immunol; 1998 Sep; 161(6):2925-9. PubMed ID: 9743354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse-human transporter.
    Yewdell JW; Esquivel F; Arnold D; Spies T; Eisenlohr LC; Bennink JR
    J Exp Med; 1993 Jun; 177(6):1785-90. PubMed ID: 8496691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain.
    Bodmer H; Viville S; Benoist C; Mathis D
    Science; 1994 Mar; 263(5151):1284-6. PubMed ID: 7510069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
    Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice.
    Barzaga-Gilbert E; Grass D; Lawrance SK; Peterson PA; Lacy E; Engelhard VH
    J Exp Med; 1992 Jun; 175(6):1707-15. PubMed ID: 1534116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes.
    Tran CN; Davis MJ; Tesmer LA; Endres JL; Motyl CD; Smuda C; Somers EC; Chung KC; Urquhart AG; Lundy SK; Kovats S; Fox DA
    Arthritis Rheum; 2007 May; 56(5):1497-506. PubMed ID: 17469112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
    Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
    J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble mouse major histocompatibility complex class II molecules produced in Drosophila cells.
    Wallny HJ; Sollami G; Karjalainen K
    Eur J Immunol; 1995 May; 25(5):1262-6. PubMed ID: 7774629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II-derived peptides can bind to class II molecules, including self molecules, and prevent antigen presentation.
    Rosloniec EF; Vitez LJ; Buus S; Freed JH
    J Exp Med; 1990 May; 171(5):1419-30. PubMed ID: 2332729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.